Starting on:
May 19, 2021
Ending on:
May 19, 2021
Moderator(s):
Venue:
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
May 19, 2021
Ending on:
May 19, 2021
Moderator(s):
THE KAREN HOSPITAL
Max Credits:
3 Points
Provider:
Karen Hospital
Claim Points
JOURNAL CLUB - 19/05/2021
Starting on:
May 19, 2021 8:00 AM
May 19, 2021 8:00 AM
Ending on:
May 19, 2021 9:30 AM
May 19, 2021 9:30 AM
Venue:
THE KAREN HOSPITAL
THE KAREN HOSPITAL
Description
The Cardiac Insufficiency Bisoprolol Study II - CIBIS II. Bisoprolol vs. placebo for mortality in heart failure.
Objectives
- In patients with heart failure, beta-blockade has improved morbidity and left-ventricular function, but the impact on survival is uncertain. We investigated the efficacy of bisoprolol, a beta1 selective adrenoceptor blocker in decreasing all-cause mortality in chronic heart failure.
- β-blocker therapy had benefits for survival in stable heart-failure patients.
- Results should not, however, be extrapolated to patients with severe class IV symptoms and recent instability because safety and efficacy has not been established in these patients.
-
Presenters
-
Dr.
Amina Abdillahi
MEDICAL OFFICER
The Karen Hospital